BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24217402)

  • 1. Relation between N-terminal pro-brain natriuretic peptide levels and response to enhanced external counterpulsation in chronic angina pectoris.
    Sahlén A; Wu E; Rück A; Hagerman I; Förstedt G; Sylvén C; Berglund M; Jernberg T
    Coron Artery Dis; 2014 Jan; 25(1):45-51. PubMed ID: 24217402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris.
    Kumar A; Aronow WS; Vadnerkar A; Sidhu P; Mittal S; Kasliwal RR; Trehan N
    Am J Ther; 2009; 16(2):116-8. PubMed ID: 19300038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina.
    Campbell AR; Satran D; Zenovich AG; Campbell KM; Espel JC; Arndt TL; Poulose AK; Boisjolie CR; Juusola K; Bart BA; Henry TD
    Am Heart J; 2008 Dec; 156(6):1217-22. PubMed ID: 19033023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year.
    May O; Lynggaard V; Mortensen JC; Malczynski J
    Scand Cardiovasc J; 2015 Feb; 49(1):1-6. PubMed ID: 25471629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina.
    Loh PH; Louis AA; Windram J; Rigby AS; Cook J; Hurren S; Nikolay NP; Caplin J; Cleland JG
    J Intern Med; 2006 Mar; 259(3):276-84. PubMed ID: 16476105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry).
    Michaels AD; Barsness GW; Soran O; Kelsey SF; Kennard ED; Hui JC; Lawson WE;
    Am J Cardiol; 2005 Feb; 95(3):394-7. PubMed ID: 15670552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).
    Soran O; Kennard ED; Kfoury AG; Kelsey SF;
    Am J Cardiol; 2006 Jan; 97(1):17-20. PubMed ID: 16377276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).
    Michaels AD; Kennard ED; Kelsey SE; Holubkov R; Soran O; Spence S; Chou TM
    Clin Cardiol; 2001 Jun; 24(6):453-8. PubMed ID: 11403506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enhanced external counterpulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris.
    Bagger JP; Hall RJ; Koutroulis G; Nihoyannopoulos P
    Am J Cardiol; 2004 Feb; 93(4):465-7. PubMed ID: 14969625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive left ventricular energetics during enhanced external counterpulsation.
    Michaels AD; Tacy T; Teitel D; Shapiro M; Grossman W
    Am J Ther; 2009; 16(3):239-46. PubMed ID: 19145208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris.
    Wu E; Mårtensson J; Desta L; Broström A
    Clin Cardiol; 2021 Feb; 44(2):160-167. PubMed ID: 33400292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of enhanced external counterpulsation on resting oxygen uptake in patients having previous coronary revascularization and in healthy volunteers.
    Ochoa AB; deJong A; Grayson D; Franklin B; McCullough P
    Am J Cardiol; 2006 Sep; 98(5):613-5. PubMed ID: 16923446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.